The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.
We hope you’ve found this article useful. We appreciate you reading and welcome your feedback if you have it.。谷歌浏览器【最新下载地址】对此有专业解读
FT Digital Edition，推荐阅读同城约会获取更多信息
Фото: Станислав Трифонов / «Лента.ру»，推荐阅读爱思助手下载最新版本获取更多信息